Sorry, you need to enable JavaScript to visit this website.
Skip to main content

All materials and content available on the website are of strictly non-promotional nature and only intended for healthcare professionals (HCPs) practicing in Europe. Kindly note that materials and content are not intended for any specific country and approval conditions for products may vary from country to country. Before prescribing any product, always refer to the approved label in the relevant country and/or the Summary of Product Characteristics.

  • February 18, 2022
  • CKD-MBD and SHPT

Emerging opportunities and challenges in SHPT

Explore the science
  • February 18, 2022
  • CKD-MBD and SHPT

Practical approaches to SHPT management in patients with ND-CKD

Explore the science
  • February 18, 2022
  • CKD-MBD and SHPT

Unmet needs in the treatment of SHPT

Explore the science
  • February 18, 2022
  • Hyperkalemia

The latest KDIGO guidelines support the use of next-generation potassium binders for the management of chronic hyperkalemia

Explore the science
  • February 18, 2022
  • Hyperkalemia

Kidney Disease: Improving Global Outcomes (KDIGO) 2020 clinical practice guidelines for diabetes management in patients with CKD

Explore the science
  • February 18, 2022
  • Hyperkalemia

The hyperkalemia challenge in patients with chronic kidney disease (CKD)

Explore the science
  • February 18, 2022
  • CKD-associated pruritus

Unmet medical needs in patients with CKD-aP: ERA–EDTA symposium 2021

Explore the science
  • February 18, 2022
  • CKD-associated pruritus

Symptom-based complications in patients undergoing dialysis

Explore the science
  • February 18, 2022
  • Iron Deficiency

Optimal anemia management in patients with chronic kidney disease (CKD): a new paradigm in treatment?

Explore the science